Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy of sclerotherapy with forced-air cooling during treatment.


Clinical Trial Description

Study Objective: The primary objective of this study is to evaluate the efficacy of sclerotherapy with forced-air cooling during treatment. Study Design: This will be an investigator-initiated, evaluator-blinded, randomized-controlled, prospective, single-center clinical trial. Study Population: 20 evaluable subjects with bilateral lower extremity reticular and telangiectatic veins, who meet all study inclusion/exclusion criteria will be considered for entry into the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04690803
Study type Interventional
Source Goldman, Butterwick, Fitzpatrick and Groff
Contact Leslie Aguilar, BA
Phone 18586571004
Email laguilar@clderm.com
Status Recruiting
Phase Phase 4
Start date January 6, 2020
Completion date December 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT00366964 - The Efficacy Of The Wavelight Mydon Laser for Hair Removal And Treatment of Leg Veins N/A
Completed NCT04004728 - Laser Treatment Of Leg Telangiectasias N/A